Half-year report · HY
7075.TEDINET S100X4E6
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.8bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥10.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥398m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥304m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥423m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥595m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥302m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥423m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥302m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥299m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥372m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥214m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥299m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥214m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥5.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥5.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥4.4bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥3.4bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.8bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥502m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥509m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥258m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥28m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥213m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥133m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥339m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥83m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥382m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥40.02 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.59 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.95 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.4 | 2025-04-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥50.01 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥29.24 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 36.9% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.8% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥180m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥180m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥27m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥784,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥784,000 |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥413m |
| Care Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.5bn |
| Care Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.5bn |
| Care Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥62m |
| Nursing Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.2bn |
| Nursing Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.2bn |
| Nursing Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥600m |
| Temporary Staffing Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥945m |
| Temporary Staffing Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥944m |
| Temporary Staffing Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥784,000 |
| Temporary Staffing Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥122m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥5.7bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥5.7bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥784,000 |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥784m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥5.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥5.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥784,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥811m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥201m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥201m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥15m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥359,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥359,000 |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥390m |
| Care Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.2bn |
| Care Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.2bn |
| Care Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥53m |
| Nursing Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.8bn |
| Nursing Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.8bn |
| Nursing Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥543m |
| Temporary Staffing Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥800m |
| Temporary Staffing Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥800m |
| Temporary Staffing Businessreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥359,000 |
| Temporary Staffing Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥83m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.8bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.8bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥359,000 |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥679m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥5.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥5.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥359,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥694m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 517
| Item | Context | Value | Unit |
|---|---|---|---|
| Amount of maintenance subsidy received inv cf | Prior1InterimDuration | － | JPY |
| Amount of maintenance subsidy received inv cf | InterimDuration | 55780000 | JPY |
| Purchase of investments in non consolidated subsidiary inv cf | Prior1InterimDuration | － | JPY |
| Purchase of investments in non consolidated subsidiary inv cf | InterimDuration | -35000000 | JPY |
| Other net inv cf | Prior1InterimDuration | -3552000 | JPY |
| Other net inv cf | InterimDuration | 7386000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration | -132772000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -27701000 | JPY |
| Increase in short term loans payable fin cf | Prior1InterimDuration | 100000000 | JPY |
| Increase in short term loans payable fin cf | InterimDuration | － | JPY |
| Decrease in short term loans payable fin cf | Prior1InterimDuration | -100000000 | JPY |
| Decrease in short term loans payable fin cf | InterimDuration | － | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -289451000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -231287000 | JPY |
| Repayments of lease obligations fin cf | Prior1InterimDuration | -3518000 | JPY |
| Repayments of lease obligations fin cf | InterimDuration | -5278000 | JPY |
| Proceeds from issuance of common stock fin cf | Prior1InterimDuration | 10200000 | JPY |
| Proceeds from issuance of common stock fin cf | InterimDuration | － | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | Prior1InterimDuration | － | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | InterimDuration | 1785000 | JPY |
| Redemption of bonds fin cf | Prior1InterimDuration | -55000000 | JPY |
| Redemption of bonds fin cf | InterimDuration | -30000000 | JPY |
| Expenditures for dividend payments fin cf | Prior1InterimDuration | -44289000 | JPY |
| Expenditures for dividend payments fin cf | InterimDuration | -74682000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -382059000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -339462000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | － | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | 163000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | -256601000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | 134645000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 1317400000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1574895000 | JPY |
| Increase in cash and cash equivalents resulting from merger with unconsolidated subsidiaries cce | Prior1InterimDuration | 44514000 | JPY |
| Increase in cash and cash equivalents resulting from merger with unconsolidated subsidiaries cce | InterimDuration | － | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 1105313000 | JPY |
| Cash and cash equivalents | InterimInstant | 1709540000 | JPY |
| Salaries and allowances sga | Prior1InterimDuration | 118242000 | JPY |
| Salaries and allowances sga | InterimDuration | 133516000 | JPY |
| Taxes and dues sga | Prior1InterimDuration | 115145000 | JPY |
| Taxes and dues sga | InterimDuration | 128379000 | JPY |
| Provision for shareholder benefit program sga | Prior1InterimDuration | － | JPY |
| Provision for shareholder benefit program sga | InterimDuration | 12110000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 1392000 | JPY |
| Provision for bonuses sga | InterimDuration | 2293000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 173000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 922000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E35344-000NursingBusinessReportableSegmentsMember | 2771204000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E35344-000CareBusinessReportableSegmentsMember | 1234293000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E35344-000TemporaryStaffingBusinessReportableSegmentsMember | 799731000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReportableSegmentsMember | 4805229000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |